RecallHawk

METHYLPHENIDATE HYDROCHLORIDE

AUROLIFE PHARMA LLC

Summary

FDA approved METHYLPHENIDATE HYDROCHLORIDE by AUROLIFE PHARMA LLC. ANDA (Generic) approval (Labeling) on 2022-09-20. TABLET, EXTENDED RELEASE, ORAL.

Details

Source

Drug Approval

External ID

ANDA206726-5

Action Date

2022-09-20

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

METHYLPHENIDATE HYDROCHLORIDE, TABLET, EXTENDED RELEASE, ORAL. Application: ANDA206726

Context & Analysis

AUROLIFE PHARMA LLC has 10 FDA actions in our database, including 3 recalls.

Frequently Asked Questions

How often does AUROLIFE PHARMA LLC have FDA actions?

AUROLIFE PHARMA LLC has 10 FDA actions in our database, including 3 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA206726-5" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions